Literature DB >> 21324794

Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway.

María Rosario García Campelo1, Guillermo Alonso Curbera, Guadalupe Aparicio Gallego, Enrique Grande Pulido, Luis Miguel Antón Aparicio.   

Abstract

Primary lung cancer may arise from the central (bronchial) or peripheral (bronchiolo-alveolar) compartments. However the origins of the different histological types of primary lung cancer are not well understood. Stem cells are believed to be crucial players in tumour development and there is much interest in identifying those compartments that harbour stem cells involved in lung cancer. Although the role of stem cells in carcinogenesis is not well characterised, emerging evidence is providing new insights into this process. Numerous studies have indicated that lung cancer is not a result of a sudden transforming event but a multistep process in which a sequence of molecular changes result in genetic and morphological aberrations. The exact sequence of molecular events involved in lung carcinogenesis is not yet well understood, therefore deeper knowledge of the aberrant stem cell fate signalling pathway could be crucial in the development of new drugs against the advanced setting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324794     DOI: 10.1007/s12094-011-0622-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  79 in total

Review 1.  Molecular regulation of lung development.

Authors:  W V Cardoso
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

Review 2.  An overview of the Notch signalling pathway.

Authors:  Martin Baron
Journal:  Semin Cell Dev Biol       Date:  2003-04       Impact factor: 7.727

Review 3.  Arteries, veins, Notch, and VEGF.

Authors:  B M Weinstein; N D Lawson
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2002

4.  Reconstitution of tracheal grafts with a genetically modified epithelium.

Authors:  J F Engelhardt; E D Allen; J M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 5.  The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.

Authors:  Corey Langer; Jean-Charles Soria
Journal:  Clin Lung Cancer       Date:  2010-03-01       Impact factor: 4.785

6.  Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.

Authors:  Cheng-Long Huang; Dage Liu; Jun Nakano; Shinya Ishikawa; Keiichi Kontani; Hiroyasu Yokomise; Masaki Ueno
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

7.  p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres.

Authors:  Pasquale Sansone; Gianluca Storci; Catia Giovannini; Silvia Pandolfi; Simona Pianetti; Mario Taffurelli; Donatella Santini; Claudio Ceccarelli; Pasquale Chieco; Massimiliano Bonafé
Journal:  Stem Cells       Date:  2006-12-07       Impact factor: 6.277

Review 8.  Hedgehog signaling: progenitor phenotype in small-cell lung cancer.

Authors:  D Neil Watkins; David M Berman; Stephen B Baylin
Journal:  Cell Cycle       Date:  2003 May-Jun       Impact factor: 4.534

9.  Neuroepithelial bodies and growth of the airway epithelium in developing hamster lung.

Authors:  R F Hoyt; S P Sorokin; E M McDowell; N A McNelly
Journal:  Anat Rec       Date:  1993-05

10.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

View more
  25 in total

1.  RBPJ inhibition impairs the growth of lung cancer.

Authors:  Qun Lv; Ronglin Shen; Jianjun Wang
Journal:  Tumour Biol       Date:  2015-01-15

Review 2.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics.

Authors:  G Paolo Dotto; Anil K Rustgi
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

Review 3.  Cancer stem cells and evolving novel therapies: a paradigm shift.

Authors:  Sangeetha Vasudevaraj Naveen; Kumar Kalaivani
Journal:  Stem Cell Investig       Date:  2018-01-23

4.  Transforming growth factor β1 enhances stemness of head and neck squamous cell carcinoma cells through activation of Wnt signaling.

Authors:  Woo-Jin Bae; Sang-Hyuk Lee; Young-Soo Rho; Bon-Seok Koo; Young-Chang Lim
Journal:  Oncol Lett       Date:  2016-11-02       Impact factor: 2.967

Review 5.  Lung cancer stem cells: a biological and clinical perspective.

Authors:  Ana Koren; Helena Motaln; Tanja Cufer
Journal:  Cell Oncol (Dordr)       Date:  2013-07-31       Impact factor: 6.730

Review 6.  Cancer stem cells in small cell lung cancer.

Authors:  Jordi Codony-Servat; Alberto Verlicchi; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

Review 7.  Lung cancer stem cells: progress and prospects.

Authors:  Amber Lundin; Barbara Driscoll
Journal:  Cancer Lett       Date:  2012-08-17       Impact factor: 8.679

8.  HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

Authors:  Hang Wang; Miqing Yang; Ling Lin; Hongzhen Ren; Chaotong Lin; Suling Lin; Guoying Shen; Binfeng Ji; Chun Meng
Journal:  Cell Oncol (Dordr)       Date:  2015-12-09       Impact factor: 6.730

9.  Maintenance of the bronchial alveolar stem cells in an undifferentiated state by secreted frizzled-related protein 1.

Authors:  Takayuki Shiomi; Piotr Sklepkiewicz; Peter V N Bodine; Jeanine M D'Armiento
Journal:  FASEB J       Date:  2014-09-11       Impact factor: 5.191

10.  Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy.

Authors:  Jun Zhao; Mark Z Ma; Hening Ren; Zhenqiu Liu; Martin J Edelman; Hong Pan; Li Mao
Journal:  Clin Cancer Res       Date:  2013-05-21       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.